Bioequivalence Protocols : In vivo/ In vitro studies

Both bioavailability and bioequivalence focus on the release of a drug substance from its dosage form and subsequent absorption into the systemic circulation. Bioavailability and Bioequivalence studies are required by regulations to ensure therapeutic equivalence between a pharmaceutically equivalent test product and a reference product. Several in vivo and in vitro methods are used to measure product quality.

  • Drug formulations
  • Fixed-dose combination products
  • Manufacturing drugs

Related Conference of Bioequivalence Protocols : In vivo/ In vitro studies

August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
August 29-30, 2018 |

International Conference and Exhibition on Drug Safety & Pharmacovigilance

Park Inn By Radisson, Toronto, Canada
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 14-15, 2018

13th International Conference on Biosimilars and Biologics

Lisbon, Portugal
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Bioequivalence Protocols : In vivo/ In vitro studies Conference Speakers

Recommended Sessions

Related Journals

Are you interested in